The role of Macklin effect in management of ARDS: beyond spontaneous pneumomediastinum

Barotrauma (including pneumomediastinum, pneumothorax or subcutaneous emphysema) is a frequent complication of patients with acute respiratory distress syndrome (ARDS) and is associated with worse outcome. Furthermore, some Authors hypothesize that pneumomediastinum could be a sign of ongoing patient self-inflicted lung injury (P-SILI) in patients with respiratory failure receiving non-invasive respiratory support. It has been recently found that a well-known radiological sign, the Macklin effect (or pulmonary interstitial emphysema), could be a powerful predictor of subsequent development of barotrauma in patients with ARDS (sensitivity = 89.2% (95% confidence interval (CI): 74.6 to 96.9); specificity = 95.6% (95% CI: 90.6 to 98.4)). Of note, Macklin effect is visible on chest computed tomography (CT) scan 8–12 days before overt barotrauma. Furthermore, patients with Macklin effect not currently receiving invasive ventilation have a high risk of subsequent intubation. Accordingly, it could be hypothesized that Macklin effect could be a marker of lung fragility, disease severity, and P-SILI in patients with ARDS. Therefore, detection of Macklin effect on chest CT scan could be used to stratify baseline risk of patients with ARDS, select which patients should be evaluated for alternative management algorithms, including advanced respiratory monitoring, ultraprotective ventilation, or institution of extracorporeal support without invasive ventilation.

Acute respiratory distress syndrome; Mechanical ventilation; Pneumothorax; Pneumomediastinum; Extracorporeal membrane oxygenation; Ventilator-induced lung injury; Barotrauma; Macklin effect

[1] Belletti A, Todaro G, Valsecchi G, Losiggio R, Palumbo D, Landoni G, et al. Barotrauma in coronavirus disease 2019 patients undergoing invasive mechanical ventilation: a systematic literature review. Critical Care Medicine. 2022; 50: 491–500.

[2] Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Medicine. 2023; 49: 727–759.

[3] Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine. 2017; 195: 438–442.

[4] Battaglini D, Robba C, Ball L, Silva PL, Cruz FF, Pelosi P, et al. Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review. British Journal of Anaesthesia. 2021; 127: 353–364.

[5] Palumbo D, Campochiaro C, Belletti A, Marinosci A, Dagna L, Zangrillo A, et al. Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: differences between first and second italian pandemic wave. European Journal of Internal Medicine. 2021; 88: 144–146.

[6] Elabbadi A, Urbina T, Berti E, Contou D, Plantefève G, Soulier Q, et al. Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients. Critical Care. 2022; 26: 350.

[7] Tonelli R, Bruzzi G, Manicardi L, Tabbì L, Fantini R, Castaniere I, et al. Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. Frontiers in Medicine. 2022; 9: 848639.

[8] Murayama S. Spontaneous pneumomediastinum and Macklin effect: overview and appearance on computed tomography. World Journal of Radiology. 2014; 6: 850–854.

[9] Angelini M, Belletti A, Landoni G, Zangrillo A, De Cobelli F, Palumbo D. Macklin effect: from pathophysiology to clinical implication. Journal of Cardiothoracic and Vascular Anesthesia. 2024; 38: 881–883.

[10] Belletti A, Pallanch O, Bonizzoni MA, Guidi L, De Cobelli F, Landoni G, et al. Clinical use of Macklin-like radiological sign (Macklin effect): a systematic review. Respiratory Medicine. 2023; 210: 107178.

[11] Palumbo D, Zangrillo A, Belletti A, Guazzarotti G, Calvi MR, Guzzo F, et al. A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients. Journal of Critical Care. 2021; 66: 14–19.

[12] Belletti A, Palumbo D, Zangrillo A, Fominskiy EV, Franchini S, Dell’Acqua A, et al. Predictors of pneumothorax/pneumomediastinum in mechanically ventilated COVID-19 patients. Journal of Cardiothoracic and Vascular Anesthesia. 2021; 35: 3642–3651.

[13] Paternoster G, Belmonte G, Scarano E, Rotondo P, Palumbo D, Belletti A, et al. Macklin effect on baseline chest CT scan accurately predicts barotrauma in COVID-19 patients. Respiratory Medicine. 2022; 197: 106853.

[14] Casadiego Monachello FJ, de la Torre Terron MC, Mendez Barraza JA, Casals Vila S. Macklin effect as an early radiological predictor of barotrauma in ARDS COVID-19 patients in invasive mechanical ventilation. Medicina Intensiva. 2023; 47: 235–236.

[15] Maccarrone V, Liou C, D’souza B, Salvatore MM, Leb J, Belletti A, et al. The Macklin effect closely correlates with pneumomediastinum in acutely ill intubated patients with COVID-19 infection. Clinical Imaging. 2023; 97: 50–54.

[16] Paternoster G, Bertini P, Belletti A, Landoni G, Gallotta S, Palumbo D, et al. Venovenous extracorporeal membrane oxygenation in awake non-intubated patients with COVID-19 ARDS at high risk for barotrauma. Journal of Cardiothoracic and Vascular Anesthesia. 2022; 36: 2975–2982.

[17] Vetrugno L, Castaldo N, Fantin A, Deana C, Cortegiani A, Longhini F, et al. Ventilatory associated barotrauma in COVID-19 patients: a multicenter observational case control study (COVI-MIX-study). Pulmonology. 2023; 29: 457–468.

[18] Valente Barbas CS, Marini Isola A, Baldisserotto S. Worsening COVID-19 acute respiratory distress syndrome: pneumomediastinum? Critical Care Medicine. 2023; 51: 145–148.

[19] Boussarsar M, Protti A. Pulmonary air leak in COVID-19: time to learn from our mistakes. Intensive Care Medicine. 2022; 48: 1614–1616.

[20] Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Critical Care and Resuscitation. 2020; 22: 95–97.

[21] Grotberg JC, Hyzy RC, De Cardenas J, Co IN. Bronchopleural fistula in the mechanically ventilated patient: a concise review. Critical Care Medicine. 2021; 49: 292–301.

[22] Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai N, et al. Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Medicine. 2016; 42: 1360–1373.

[23] Tonelli R, Fantini R, Tabbì L, Castaniere I, Pisani L, Pellegrino MR, et al. Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure. A pilot study. American Journal of Respiratory and Critical Care Medicine. 2020; 202: 558–567.

[24] Jonkman AH, Telias I, Spinelli E, Akoumianaki E, Piquilloud L. The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects. European Respiratory Review. 2023; 32: 220186.

[25] Sartini C, Tresoldi M, Scarpellini P, Tettamanti A, Carcò F, Landoni G, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA. 2020; 323: 2338–2340.

[26] Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, et al. Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 2022; 10: 573–583.

[27] Stilma W, Åkerman E, Artigas A, Bentley A, Bos LD, Bosman TJC, et al. Awake proning as an adjunctive therapy for refractory hypoxemia in non-intubated patients with COVID-19 acute respiratory failure: guidance from an international group of healthcare workers. American Journal of Tropical Medicine and Hygiene. 2021; 104: 1676–1686.

[28] Pasin L, Dagna L, Consonni M, Boraso S, Munari M, Romero García CC, et al. Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis. Signa Vitae. 2023; 19: 31–36.

[29] Belletti A, Sofia R, Cicero P, Nardelli P, Franco A, Calabrò MG, et al. Extracorporeal membrane oxygenation without invasive ventilation for respiratory failure in adults: a systematic review. Critical Care Medicine. 2023; 51: 1790–1801.

[30] Murselović T, Berić S, Makovšek A. Pitfalls of difficult extubation in the ICU; when is the right time to extubate a patient? Signa Vitae. 2024; 20: 22–26.

[31] Belletti A, D’Andria Ursoleo J, Piazza E, Mongardini E, Paternoster G, Guarracino F, et al. Extracorporeal membrane oxygenation for prevention of barotrauma in patients with respiratory failure: a scoping review. To be published in Artificial Organs. 2024. [Preprint].

[32] Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO Journal. 2021; 67: 601–610.

[33] Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators; Cavalcanti AB, Suzumura ÉA, Laranjeira LN, Paisani DM, Damiani LP, Guimarães HP, et al. Effect of lung recruitment and titrated Positive End-Expiratory Pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome—a randomized clinical trial. JAMA. 2017; 318: 1335–1345.

[34] McNamee JJ, Gillies MA, Barrett NA, Perkins GD, Tunnicliffe W, Young D, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial. JAMA. 2021; 326: 1013–1023.